Trending News

#Covid-19 #Immunology / Virology & Vaccines

COVID-19 vaccine trial results: a watershed moment says immunology expert

The first effective coronavirus vaccine can prevent more than 90% of people from getting Covid-19, a preliminary analysis has shown. The developers – Pfizer and BioNTech – described it as a “great day for science and humanity”. The analysis evaluated 94 confirmed cases of COVID-19 in trial participants. Daniel Davis,… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Pfizer and BioNTech vaccine COVID-19 candidate found to be more than 90% effective

Pfizer and BioNTech have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee (DMC) from the Phase… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Assay development optimisation & technology #Drug discovery #High Content Screening #RNA

PerkinElmer to acquire Horizon Discovery for $383 million

PerkinElmer will acquire Horizon Discovery for approximately $383 million (£296 million). The transaction is expected to close in the first quarter of 2021 subject to conditions. The investment will allow PerkinElmer to expand its portfolio of leading, automated life sciences discovery and applied genomics solutions to include gene editing and… Read More

#News #Trending News

#Cancer research #Immunotherapy

Scientists engineer new cancer immunotherapy to train immune system in cancer fight

A new type of cancer immunotherapy developed at the Icahn School of Medicine at Mount Sinai trains the innate immune system to help it eliminate tumour cells through the use of nanobiologics, tiny materials bioengineered from natural molecules that are paired with a therapeutic component, according to a study published… Read More

#Cancer Research #News #Trending News

#Antibodies #Covid-19 #Novel candidates #Therapeutics

Novel COVID-19 antibody therapy candidates identified by UK biotech consortium

The UK BIA Antibody Taskforce, a UK consortium developing antibodies for treating COVID-19 has reached a major milestone – the identification of differentiated antibody combinations that will be taken forward for further development as an antibody ‘cocktail’. The Taskforce developed an accelerated and rigorous multifaceted approach to create a pool… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Drug development #Drug discovery #Oncology

New drug for difficult-to-drug cancer mutation could be key treatment for other cancers

A new drug designed to counter the effects of an important, but very hard to target, cancer mutation could be effective against a range of tumour types including lung and gynaecological cancers, a new clinical trial shows. Researchers used an innovative, intermittent treatment schedule to limit the drug’s toxicity, and… Read More

#Cancer Research #News #Trending News

#Cell therapy #Gene therapy

Bayer acquires AskBio to broaden innovation in cell and gene therapy

Bayer has acquired Asklepios BioPharmaceutical (AskBio) a US-headquartered biopharmaceutical company specialising in the research, development and manufacturing of gene therapies across different therapeutic areas. AskBio’s development portfolio includes investigational pre-clinical and clinical stage candidates for the treatment of neuromuscular, central nervous system, cardiovascular and metabolic diseases. Bayer will own full… Read More

#News #Trending News

#Covid-19 #Immunology / Virology & Vaccines

Oxford COVID-19 vaccine follows genetic instructions, analysis finds

The AstraZeneca Oxford COVID-19 vaccine (ChAdOx1 nCoV-19 and also known as AZD1222) has been shown to work as planned. A team at Bristol University has used recently developed techniques to further validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford team. This novel analysis… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Covid-19 #Immunology / Virology & Vaccines

Survey finds three in ten Americans unwilling to have COVID vaccine

Almost seven in 10 Americans would be interested in receiving a COVID-19 vaccine, a study finds. But researchers say there are concerning gaps in interest, particularly among Black Americans, who suffer disproportionately from the virus. Researchers from The Ohio State University surveyed more than 2,000 Americans, asking them about their… Read More

#Covid-19 #News #Trending News

#Institute of Cancer Research #Oncology #Precision medicine

Combining precision medicines can treat drug-resistant cancers

Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could treat patients with multiple common cancers, a new clinical trial shows. It is the first trial to use the pioneering genetically targeted drug olaparib – already licensed for ovarian, breast and prostate cancer – together… Read More

#Trending News

Sanofi to acquire Principia Biopharma

17 August 2020 Image: Cytonn Photography Sanofi has agreed to buy Principia Biopharma, a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases for $3.7 billion. “This acquisition advances our ongoing R&D transformation to accelerate development of the most promising medicines that will address significant patient needs,”… Read More

#News #Trending News

Discovery show promise for treating Huntington’s Disease

14 August 2020 Image: Morgan Housel Scientists at EPFL’s Brain Mind Institute have identified an enzyme that can play a central role in developing a new route of treatment for Huntington’s Disease. Huntington’s disease is a progressive and aggressively debilitating brain disorder that causes uncontrolled movements, psychological problems,… Read More

#News #Trending News

Five biomarkers linked to severe COVID-19 outcome

George Washington University researchers analysed five biomarkers present in the blood of hundreds of COVID-19 patients, finding elevated levels associated with higher odds of clinical deterioration and death. “When we first started treating COVID-19 patients, we watched them get better or get worse, but we didn’t know why,”… Read More

#Covid-19 #News #Trending News